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ABSTRACT The kinetics of formation and transformation of oxygen complexes of two heme-thiolate proteins (the F393H
mutant of cytochrome P450 BM3 and the oxygenase domain of endothelial nitric oxide synthase, eNOS) were studied under high
pressure. For BM3, oxygen-binding characteristics (rate and activation volume) matched those measured for CO-binding. In
contrast, pressure revealed a different CO- and oxygen-binding mechanism for eNOS, suggesting that it is hazardous to take CO-
binding as amodel for oxygen-binding.With eNOS, a ferric NO complex is formed as an intermediate in the second reaction cycle.
Here we report the pressure stability of this compound. Furthermore, in the presence of 4-amino-tetrahydrobiopterin (ABH4), an
analog to the natural second electron donor tetrahydrobiopterin (BH4), biphasic pressure proﬁles of the oxygen-binding rates
were observed, both in the ﬁrst and the second reaction cycles, indicative of the formation of an additional reaction intermediate.
This was conﬁrmed by experiments where ABH4 was replaced by ABH2, a cofactor which cannot deliver an electron. Altogether,
high pressure appears to be a useful tool to characterize elementary steps in the reaction cycle of heme-thiolate proteins.
INTRODUCTION
Cytochromes P450 and nitric oxide synthases are among the
most intensively studied of all enzymes. The many hundred
known forms of cytochrome P450 are notably involved in
detoxiﬁcation of xenobiotics and steroid biosynthesis, but
also in adverse reactions such as activation of procarcinogens
(Lewis, 2001; Lange, 2003). The three forms of nitric oxide
synthase (neuronal, endothelial, and inducible) participate in
diverse physiological processes, such as neuromodulation,
vasodilatation, and immune response (Marletta et al., 1998;
Pfeiffer et al., 1999; Stuehr, 1999). Depending on the cir-
cumstances, their action can be beneﬁcial for the organism or
lead to severe pathologies (Grisham et al., 1999; Davis et al.,
2001). Of course, any attempt tomodulate the activity of these
enzymes requires an understanding of the catalytic steps at the
molecular level. In both enzymes catalysis takes place at
a thiolate-ligated heme. This structural property is reﬂected by
a similar reaction mechanism with oxygen, in which a ferrous
oxygen complexmust be ‘‘activated’’ by the input of a second
electron, leading ﬁnally to the incorporation of one oxygen
atom into an organic substrate and to the formation of a water
molecule. Several intermediate states, including higher
valence iron oxygen complexes, are hypothesized (Ortiz de
Montellano, 1995).
The interaction with oxygen is a key feature of the reaction
mechanism of these enzymes. Oxygen-binding has been
studied for a number of cytochrome P450 forms and nitric
oxide synthase, both spectroscopically (at subzero temper-
atures), and by stopped-ﬂow. However, little is known about
the mechanism of this reaction in terms of elementary steps.
For a better understanding of the steps involved,we undertook
their kinetic analysis under high pressure. The effect of
pressure is of interest since it can be used as a complementary
thermodynamic parameter to temperature: it is a relatively
mild structural perturbant speciﬁcally affecting electrostatic
and hydrophobic interactions (Mozhaev et al., 1996). These
perturbation properties have been used with success to
explore structural and dynamic properties of the heme pocket
(Bancel et al., 2002). Furthermore, the high pressure stopped-
ﬂow method (Balny et al., 1984) allowed us to relate kinetic
aspects of hemoproteins to the nature of their proximal axial
ligands (Lange et al., 1994). In this study we compare the
pressure dependence of oxygen- and CO-binding rates for
heme-thiolate enzymes. From the pressure dependence of the
rate constants the activation volume,DVz, is then determined.
The latter parameter informs us about structural features of the
transition state of the reaction, where its sign and absolute
value reﬂect type and extent of protein conformational
changes and protein hydration changes within an elementary
reaction step.
The high pressure approach is applied here to the study of
the F393H mutant of cytochrome P450 BM3 (BM3) and the
oxygenase domain of endothelial nitric oxidase (eNOS).
These ﬂavocytochrome enzymes operate similar electron
transport chains, with electrons delivered from NADPH by
a diﬂavin reductase (a P450 reductase-like FAD- and FMN-
containing enzyme) fused to the heme-containing oxygenase
domain. The strong reactivity of wild-type P450 BM3 with
oxygen means that the complex is transient, collapsing
rapidly to generate ferric heme and superoxide. However, the
F393H mutant has heme thermodynamic features altered
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from the wild-type; speciﬁcally, a more positive heme iron
reduction potential and a stabilized ferrous-oxy form (Ost
et al., 2001). The properties of the F393H mutant enable the
kinetics of the binding reaction between P450 and oxygen to
be analyzed and compared with the reaction with carbon
monoxide (which forms a stable ferrous complex with both
wild-type and F393H BM3).
The oxygenase domain of endothelial NOS is the part of
nitric oxide synthase that resembles most closely a cyto-
chrome P450. Our previous studies on the eNOS oxygenase
domain have shown it to be active (in the formation of
product). For an input of electrons, it does not speciﬁcally
require the presence of the reductase domain. The kinetics of
the formation of the NOS oxycomplex have been reported by
Stuehr’s group (Abu-Soud et al., 1997, 2000; Boggs et al.,
2000). Our previous spectroscopic work at subzero temper-
atures has shown the possibility of stabilizing the oxygen
complex of these enzymes. One important difference between
P450 and NOS is that NOS requires the presence of tetra-
hydrobiopterin (BH4) as cofactor. We have recently shown
that BH4 is a redox partner of NOS in the ﬁrst and the second
reaction cycles (Bec et al., 1998; Gorren et al., 2000). An
analogous compound, 4-amino-tetrahydrobiopterin (ABH4),
is an inhibitor of the NOS reaction. However, as we observed
recently, its presence signiﬁcantly affects the absorbance
spectrum of NOS oxygen intermediate complexes (Gorren
et al., 2000). In our present experiments, we have compared
the effects of BH4, ABH4, and ABH2 (the oxidized form of
ABH4) on the reaction of eNOS with oxygen. The high
pressure stopped-ﬂow kinetic approach is shown to help in the
mechanistic understanding of these physiologically important
reactions.
MATERIALS AND METHODS
Enzymes
The F393H heme domain of P450 BM3 was prepared from TG1
transformants of the mutant clone, as described previously (Ost et al.,
2001). Escherichia coli cell growth and the extraction and puriﬁcation of
protein were largely as described in previous publications (Ost et al., 2001;
Noble et al., 1999). Transformant cells (typically 5 liters of cell culture) were
induced (with 1 mM IPTG) at an OD600¼ 1, and growth was continued for
6–12 h before harvesting cells. Cells were disrupted by two passes through
a French press (950 psi) followed by sonication (10 3 15 s bursts on
a Sonopuls sonicator (Bandelin, Berlin, Germany) set at 90% power, with
cooling on ice between bursts). Enzyme was puriﬁed using ion exchange
chromatography on DEAE-Sephacel and hydroxyapatite, as described
previously (Noble et al., 1999). Phenylmethylsulfonyl ﬂuoride (1 mM) was
added to all buffers to minimize proteolysis. Enzyme was concentrated to
;1 mM by ultraﬁltration and dialyzed into 50 mM TrisHCl at pH 7.0,
containing 50% (v/v) glycerol before storage at –808C. Enzyme was used
within 1 month of puriﬁcation. Enzyme concentration and integrity was
determined by preparation of the ferrous-CO complex, as described
previously. Complete conversion to the P450 form (with absorption
maximum at 445 nm for the F393H mutant) was observed, with negligible
absorption in the region of 420 nm, indicating homogeneous native enzyme.
The heme domain of ﬂavocytochrome P450 BM3 was predominantly
monomeric in solution.
The eNOS oxygenase domain was cloned and puriﬁed from E. coli cells
as described previously (Gorren et al., 2000). Its concentration was
determined from the absorption coefﬁcient of the ferrous-CO complex
according to Sono et al. (1995).
Reagents
BH4 and NOHLA were from Alexis Biochemicals (Lausen, Switzerland);
4-aminotetrahydrobiopterin [(6R)-2,4-diamino-5,6,7,8-tetrahydro-6-(L-eryth-
ro-19,29-dihydroxypropyl)pterin, ABH4] and 4-amino-7,8-dihydro-L-bio-
pterin (ABH2) were purchased from Schircks Laboratories (Jona,
Switzerland); L-arginine, CHAPS (3-[(cholamidopropyl)-dimethylammo-
nio]-1-propanesulfonate), and sodium dithionite were from Sigma-Aldrich
(Saint Quentin Fallavier, France). Oxygen and CO (99.995% pure) were
from Aga (Toulouse, France). All other materials were reagent-grade or
better, and were used without further puriﬁcation.
Experimental procedure
Single turnover experiments under high pressure were performed using
a high-pressure stopped-ﬂow apparatus built in our laboratory (Balny et al.,
1984). Kinetics were determined bymixing equal volumes of the enzyme and
ligand solutions in a thermostated high-pressure stopped-ﬂow cell placed in
an Aminco DW2 spectrophotometer (SLM Instruments, Urbana, IL) operat-
ing in dual wavelength mode. The buffers were: 50 mM KPi pH 7.5, 1 mM
CHAPS, 0.5 mM EDTA, 1 mM 2-mercaptoethanol (NOS), and 50 mM
MOPS at pH 7.4 (BM3). Enzyme and gas-saturated solutions were prepared
as already described (Gorren et al., 2000 ; Lange et al., 2001). Brieﬂy, enzyme
solutions were deoxygenated under argon atmosphere and then reduced by
sodium dithionite (1 mM ﬁnal concentration). During this time, O2- and CO-
saturated solutions were prepared by bubbling the buffers with O2 or CO for
45 min. The concentration of these stock solutions was estimated to be 1 mM
CO or O2 at 258C.
The experiments were set up with one syringe ﬁlled with reduced enzyme
in the presence of substrate and cofactor and the other one containing the O2-
or CO-saturated solution. Kinetics were recorded in the dual wavelength
mode (absorbance difference between two simultaneously recorded wave-
lengths). For the formation of the ferrous oxygen complex we used the
couples 431/412, 423/412, and 435/405 nm for NOS in the presence of
L-Arg or NHA, and for BM3, respectively. The kinetics of the formation of
the FeIII-NO complex were recorded at 437/413 nm. For the CO-binding
kinetics, we used the wavelength couples 447/413 and 449/409 nm for
eNOS and BM3, respectively.
Kinetic data analysis and determination of DVz
First-order rate constants were obtained by nonlinear least-square analysis
using a ﬁtting program developed in the laboratory (Balny et al., 1984). In
our conditions, the kinetic traces were well-ﬁtted by a mono-exponential
equation. An average from four kinetic traces was recorded at each pressure.
From the pressure-dependent rate constant, kobs, the activation volume DV
z
was calculated according to Eq. 1,
ðd ln kobs=dPÞT ¼ DVz=RT; (1)
where P is the hydrostatic pressure, T the absolute temperature, and R the gas
constant (8.2 ml MPa mol1 K1).
RESULTS
Oxygen- and CO-binding to BM3
Binding of oxygen as well as of CO to dithionite-reduced
BM3 produced monoexponential kinetics. The thermody-
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namic effects on the heme iron in the F393H mutant resulted
in stabilization of the ferrous-oxy complex without any
signiﬁcant changes in the structure of the protein. Indeed, the
relevant mutation is located on the proximal side of the heme
and does not affect the oxygen-binding site, or access to the
distal face of the heme. The logarithm of the observed
binding-rate constant, kobs, decreased linearly as a function
of pressure, with very comparable activation volumes of DVz
¼ 9–10 ml/mol (See Fig. 1 and Table 1). Previous kinetic
work as a function of CO concentration (Lange et al., 1994)
indicates that our conditions reﬂect pseudo-ﬁrst-order
kinetics. High pressure increased to some extent the stability
of the oxygen complex: the decomposition rate constant
decreased exponentially as a function of pressure with an
activation volume of 3.1 ml/mol.
Oxygen-binding to eNOS in the presence of ABH2
To compare oxygen-binding of BM3 and eNOS, care has to
be taken that the oxygen complex which is formed with
eNOS does not evolve further to an activated complex via
reduction by a second electron. BH4 can donate this second
electron. However, ABH2 cannot deliver an electron.
Therefore, we measured oxygen-binding to eNOS in the
presence of ABH2. As shown in Figs. 2 and 3, the oxygen-
binding rate varies linearly as a function of pressure. It
decreases with pressure in the ﬁrst reaction cycle (in the
presence of L-Arg), and it increases in the second reaction
cycle (in the presence of NOHLA). The rate of the oxygen
complex decay is nearly pressure-independent in the ﬁrst
reaction cycle, and it decreases strongly as a function of
pressure in the second reaction cycle. The thermodynamic
parameters are listed in Table 1.
CO-binding to eNOS
As we have already shown, at atmospheric pressure, the CO-
binding rate was considerably slower (by a factor of 10) than
oxygen-binding (Lange et al., 2001). However, the CO-
binding rate increased strongly as a function of pressure,
attaining a threefold higher value at 140 MPa (see Fig. 4 and
Table 1). This pressure-induced increase of the CO-binding
rate is reﬂected by an activation volume of DVz¼16.7 ml/
mol. The CO-binding rate and its activation volume were not
signiﬁcantly affected by the nature of the pterin cofactor
(ABH4 or ABH2). Furthermore, the kinetics did not depend
on the nature of the substrate (L-Arg or NOHLA).
Interaction of eNOS with oxygen in the presence
of BH4
In the course of the second reaction cycle of NOS, i.e., in the
presence of NOHLA, interaction of reduced eNOS with
oxygen results in the transient formation of a ferric NO
complex. Low temperature studies have shown that this
reaction requires the presence of its natural cofactor BH4. It
does not require the presence of the reductase domain (Gorren
et al., 2000). The FeIII-NO complex is characterized by an
absorbance maximum near 440 nm. In our present study we
studied the formation and decomposition of this complex
under high pressure. As shown in Fig. 5, its formation was
very rapid even at 58C. It was completed within 100 ms. The
decomposition was ;103 slower. The logarithmic decom-
position rate decreased linearly as a function of pressure with
an activation volume of DVz ¼ 7 ml/mol.
Interaction of eNOS with oxygen in the presence
of ABH4
ABH4 is a strong inhibitor of NOS activity (Werner et al.,
1996; Pfeiffer et al., 1997). Nevertheless, an electron transfer
from ABH4 to the oxygen complex cannot be excluded. It
was therefore interesting to study the pressure dependence of
this reaction. Our previous low temperature work (Gorren
et al., 2000) had revealed that oxygen-binding to reduced
eNOS in the presence of ABH4 results in optically detectable
oxygen complexes within the ﬁrst reaction cycle (in the
FIGURE 1 Pressure effect on oxygen and CO complex formation of
BM3. Reduced BM3 (2 mM) was mixed in the presence of 60 mM
arachidonate with CO or oxygen (0.5 mM) in 50 mM MOPS buffer at pH
7.4. (Upper graph) CO-binding rate () and O2-binding rate (d). (Lower
graph) Decomposition of the oxygen complex. Data points were the average
of three independent experiments. SE on each average was\5%.
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presence of L-Arg) as well as in the second reaction cycle (in
the presence of NOHLA). Figs. 2 and 3 show the pressure
dependence of the complex formation and decomposition
kinetics. For both reaction cycles, the pressure dependence
of the oxy-complex formation was biphasic: up to;50 MPa,
the rate increased. Above this pressure, the rate decreased.
This effect was especially important within the second
reaction cycle: the activation volume changed from DVz ¼
42 ml/mol (\50 MPa) to DVz ¼ 19 ml/mol ([50 MPa).
In contrast, the pressure dependence of the oxygen complex
decomposition rate did not show a break. In the ﬁrst reaction
cycle, the activation volume was nearly pressure-indepen-
FIGURE 2 Pressure effect on formation and decomposition of the oxygen
complex of eNOS in the ﬁrst reaction cycle. (Upper graph) Formation of the
oxygen complex. (Lower graph) Decomposition of the oxygen complex in
the presence of ABH4 (d) and in the presence of ABH2 (D). Exponential
bursts of oxycomplex production and breakdown were followed by rapidly
mixing a solution containing 7 mM ferrous enzyme, 500 mM arginine, and
50 mM ABH4 or ABH2 with an oxygen-saturated buffer solution at 48C.
Three independent experiments were performed to determine the rate
constant at each pressure. SE on each experimental point was\2%.
TABLE 1 Thermodynamic activation parameters of O2- and CO-binding to P450 BM3 and NO synthase
O2-binding CO-binding
Substrate k
p
obs ¼ 0.1 MPa (s1) DVz (ml/mol1) kpobs ¼ 0.1 MPa (s1) DVz (ml/mol1)
P450 BM3 Arachidonate 10.0 6 0.1 18.9 6 0.1 10.6 6 0.2 110.8 6 0.2
NO synthase
1amino BH4 L-Arg 6.8 6 0.1 5.1 6 0.1 (0.1–55 MPa) 1.1 6 0.1
1 6.5 6 0.1 (55–90 MPa)
1 amino BH2 L-Arg 9.1 6 0.1 112.3 6 0.1 0.9 6 0.1 16.7 6 0.2
1amino BH4 NHA 2.2 6 0.1 42.1 6 0.2 (0.1–48 MPa) 1.0 6 0.1
19.0 6 0.1 (48–90 MPa)
1 amino BH2 NHA 6.7 6 0.1 6.9 6 0.1 0.9 6 0.1
FIGURE 3 Pressure effect on formation and decomposition of the oxygen
complex of eNOS in the second reaction cycle. (Upper graph) Formation of
oxygen complex. (Lower graph) Decomposition of oxygen complex in the
presence of ABH4 (d) and in the presence of ABH2 (D). The experimental
conditions were those of Fig. 2 except with NOHLA, 1 mM, as substrate, in
the place of L-Arg.
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dent (DVz ¼ 3.3 ml/mol). However, in the second reaction
cycle, the decomposition rate decreased strongly as a func-
tion of pressure with an activation volume of DVz¼ 25.4 ml/
mol.
DISCUSSION
Although the interaction of reduced heme-thiolate proteins
with molecular oxygen plays a central role in the reaction
mechanism, it is always difﬁcult to study this reaction. This
is due to the transient nature of the ferrous oxygen complex:
in the absence of a speciﬁc electron donor it decomposes
quickly to ferric enzyme and superoxide, and in the pres-
ence of an electron donor it transforms immediately to an
activated complex leading to product release. Apart from the
relatively stable oxygen complex of cytochrome P450cam,
which can be observed for a couple of minutes (Bangchar-
oenpaurpong et al., 1986), the detection of oxygen
complexes with other P450 forms requires the use of low-
temperature spectroscopic techniques (Bonﬁls et al., 1979;
Larroque and van Lier, 1980). But even for P450cam, a closer
structural inspection needs cryogenic techniques (Vidakovic
et al., 1998; Schlichting et al., 2000; Denisov et al., 2002).
Similarly, for nitric oxide synthase, oxygen complexes have
been observed by low-temperature spectroscopy (Bec et al.,
1998; Ledbetter et al., 1999). In this article, stopped-ﬂow
kinetics of oxygen-binding under high pressure are reported
for the ﬁrst time. In the past, we had used high pressure
stopped-ﬂow (HPSF) to study the mechanism of CO-binding
to heme-thiolate enzymes (Lange et al., 1994; Jung et al.,
2002). The work with oxygen became feasible now after an
instrumental adaptation (use of a ruby sphere acting as an
inner valve), and by a very careful design of anaerobic
experimental conditions: the concentration of dithionite must
be high enough to ensure enzyme reduction, and sufﬁciently
low to prevent reduction of oxygen.
Oxygen-binding to BM3 and eNOS
To study oxygen-binding, we chose conditions under which
the oxygen complexes could not evolve further in the
reaction cycles. That is, for BM3 we worked with the
oxygenase domain (the absence of the reductase domain
preventing a reduction by a second electron). For eNOS, we
replaced BH4 by ABH2, a cofactor which cannot deliver
a second electron. As one may expect, oxygen-binding to
BM3 appears to occur via the same mechanism as CO-
binding with similar rate constants and the same activation
volumes. The oxygen-binding mechanism of eNOS appears
not to be very different from that of BM3: the observed rate
constants are comparable, and in the ﬁrst reaction cycle, i.e.,
with L-Arg as substrate, the activation volume of the
complex formation is similar. However, within the second
reaction cycle, the activation volume is negative (it is
positive in the ﬁrst cycle). This means that the oxygen
complex formation is accelerated by pressure within the
second cycle. This points to a different binding mechanism
in the two reaction cycles.
In contrast to BM3, in eNOS the mechanism of oxygen-
binding is very different from that of CO-binding. Indeed,
whatever the cofactor or the substrate, the CO-binding rate
was ;73 lower at atmospheric pressure. However, it in-
FIGURE 4 Kinetics of CO complex formation of eNOS. Effect of ABH4
in the presence of L-Arg (d) and NOHLA (); effect of ABH2 in the
presence of L-Arg (.) and NOHLA (,). Conditions before mixing: 50 mM
ABH4 or ABH2, 500 mML-Arg or 1 mMNOHLA and 7 mM enzyme. Three
independent experiments were performed to determine the rate constant at
each pressure.
FIGURE 5 Pressure effect on formation and decomposition of the FeIII-
NO complex of eNOS. The complex was observed after mixing of reduced
eNOS (3.5 mM ﬁnal) in the presence of NOHLA (500 mM) and BH4 (25
mM) with oxygen (0.5 mM ﬁnal) at 48C. The complex formation and
decomposition were followed at 437 nm. Three independent determinations
were performed to determine the rate constants at each pressure. SE of each
experimental point was \2%. (Inset) Time course of the O2-binding to
eNOS after stopped-ﬂow mixing at 50 MPa. The solid line shows the mono-
exponential ﬁt for the decomposition kinetics of the ferric NO complex.
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creased strongly under high pressure. In our previous
work, we had explained the low reactivity of eNOS with
CO at atmospheric pressure in terms of inaccessibility of CO
to the heme iron when substrate was present. Indeed, in the
absence of substrate, the CO-binding rate is considerably
higher (Lange et al., 2001). The effect of pressure was then
attributed to an expulsion of the substrate of the active center,
facilitated by the CO-binding. However, if the presence of
substrate obstructs the active site for CO-binding, one may
expect a similar effect on oxygen-binding, and high pressure
should accelerate oxygen-binding. Since this is not the
case, we must conclude that 1), oxygen- and CO-binding
mechanisms in eNOS are different; 2), the CO-binding
mechanisms of BM3 and eNOS are different; and 3), care
must be taken in using CO-binding as a model for oxygen-
binding. In the latter case, using CO-binding as a model for
O2-binding in eNOS appears highly inappropriate. The fact
that O2 binds up to 10-fold faster than does CO at at-
mospheric pressure suggests the existence of a speciﬁc path-
way of oxygen entry into the eNOS active site.
Formation and decay of FeIII-NO
In the presence of BH4 and NOHLA, the ferrous oxygen
complex of eNOS was not detected. Instead, as previously
reported, the ﬁrst detectable intermediate was the ferric NO
complex (Bec et al., 2000). Thus, our stopped-ﬂow experi-
ments reﬂected formation and decay of this intermediate
state as a function of pressure. The rather small activation
volume of its decay rate, as well as its linear logarithmic
pressure dependence, indicate that no further intermediate in
the reaction cycle may be expected, and that the trans-
formation from FeIII-NO to FeIII is not accompanied by
a major protein conformational change.
The case of ABH4
It is more difﬁcult to interpret the results obtained in the
presence of ABH4. In its presence, product is not formed,
and consequently we did not observe a ferric NO complex.
However, the pressure dependence of the oxygen-binding
rate constant shows a break, both in the ﬁrst and in the
second reaction cycle. This break can be interpreted in two
ways: 1), high pressure induces a transition between two
protein conformers of different oxygen-binding properties;
and 2), in the presence of ABH4 oxygen-binding is followed
by another reaction, and at high pressure a change of the rate-
limiting step takes place.
Support for the ﬁrst hypothesis comes from nonlinear
pressure dependence of ligand-binding rates of myoglobin
(mb) which have been attributed to a pressure-induced
transition between two protein conformers (Uchida et al.,
2000). Althoughmb has a different heme ligation (imidazole)
than P450 and NOS (thiolate), and different ligand-binding
mechanisms can be expected, recent progress in the under-
standing of ligand-binding to mb may be relevant also for
P450 and NOS. Indeed, CO-binding to mb has been shown
to proceed via different paths, comprising different CO
‘‘docking sites’’ (Sˇrajer et al., 2001; Lamb et al., 2002). These
docking sites are related to protein cavities or packing defects
(Chu et al., 2000; Brunori and Gibson, 2001) that may
conceivably change size under pressure. Further support for
the conformational explanation comes from ﬂush-photolysis
experiments of geminate CO rebinding to P450 and NOS,
which gave evidence of doublet substate conformers of
different CO-binding characteristics (Te´treau et al., 1997,
1999). Moreover, a high pressure stopped-ﬂow study of CO-
binding to P450cam also revealed the coexistence of confor-
mers of different activation volumes DVz (Jung et al., 2002).
However, despite many of the conformational arguments
given above, the second hypothesis, which assumes an
additional reaction step in the presence of ABH4, appears
to be more plausible. Indeed, we found a linear pressure
dependence of the oxygen-binding rate for BM3 as well as
for NOS. A pressure break was only observed with NOS
when ABH2 was replaced by ABH4. Since ABH2 and ABH4
have the same structure, they differ only in their oxida-
tion state, so a differential effect on oxygen-binding rates un-
der pressure would be difﬁcult to explain. However, unlike
ABH2, ABH4 could play an electron donor role, like
authentic BH4. A possible interpretation of the additional
reaction step would therefore be that the formation of the
ferrous oxygen complex is followed by its reduction via
ABH4. If this hypothesis is correct, then we do not know
exactly which step we are following; it can be the oxygen
complex formation as well as its reduction. However, the
break in the pressure proﬁle would then indicate a change of
the rate-limiting step. Interestingly, since we do not observe
an FeIII-NO complex, the reduction of the oxygen complex
by ABH4 may lead only to a peroxy complex which does
not evolve further to the higher valence iron-oxo com-
plex considered to be the catalytically active species. The
possibility of ABH4 acting as a mechanism-based inhibitor is
intriguing, but needs to be proven. One possibility to decide
between the conformational and the mechanistic explan-
ations would be to carry out HPSF experiments with spectral
resolution. The instrumental setup for such experiments is
currently being built in our laboratory.
CONCLUSION
The above results show the potential of the HPSF technique
to study enzyme elementary steps as a complement to
conventional stopped-ﬂow technique. With respect to high
temperature, high pressure offers the possibility to study
enzyme reactions without denaturing the protein. Instead,
pressure may be used to switch from one elementary step to
another. This possibility appears to be particularly important
to study complex reactions such as reaction cycles occurring
in hemoproteins.
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